Evidence map›Paper›PMID 31950099›Full record

ArticleBrain circulation

Cofilin-actin rod formation in experimental stroke is attenuated by therapeutic hypothermia and overexpression of the inducible 70 kD inducible heat shock protein (Hsp70).

Kota Kurisu, Jesung You, Zhen Zheng, Seok Joon Won, Raymond A Swanson, Midori A Yenari

Open access · diamondAbstract read
In one paragraph

Article in Brain circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Resveratrol Preconditioning Protects Against Ischemia-Induced Synaptic Dysfunction and Cofilin Hyperactivation in the Mouse Hippocampal Slice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  3. Article
  4. Review
  5. Review
  6. Cofilin Signaling in the CNS Physiology and Neurodegeneration.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Kota KurisuUniversity of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Jesung YouUniversity of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Zhen ZhengUniversity of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Seok Joon WonUniversity of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Raymond A SwansonUniversity of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Midori A YenariUniversity of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
San Francisco VA Medical Center · USUniversity of California, San Francisco · US

Funding

Inflammatory mechanisms in cerebral ischemiaR01NS106441 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YENARI, MIDORI A · 2019 to 2023
$1.7M
Calcium release-activated calcium (CRAC) channel inhibitors in experimental strokeR03NS101246 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YENARI, MIDORI A · 2017 to 2018
$153k
Heat shock proteins in brain ischemia and strokeI01BX000589 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI YENARI, MIDORI A · 2011 to 2019
–
BLRD VA I01 BX000589NINDS NIH HHS R01 NS106441NINDS NIH HHS R03 NS101246
6 · The paper itself

Abstract

background and purposeCofilin-actin rods are covalently linked aggregates of cofilin-1 and actin. Under ischemic conditions, these rods have been observed in neuronal dendrites and axons and may contribute to the loss of these processes. Hypothermia (Hypo) and the 70 kD inducible heat shock protein (Hsp70) are both known to improve outcomes after stroke, but the mechanisms are uncertain. Here, we evaluated the effect of these factors on cofilin-actin rod formation in a mouse model of stroke. MATERIALS AND

methodsMice were subjected to distal middle cerebral artery occlusion (dMCAO) and treated with Hypo using a paradigm previously shown to be neuroprotective. We similarly studied mice that overexpressed transgenic (Tg) or were deficient knockout (Ko) in the inducible 70 kDa heat shock protein (Hsp70), also previously shown to be protective by our group and others. Cofilin-actin rod formation was assessed by histological analysis at 4 and 24 h after dMCAO. Its expression was analyzed in three different regions, namely, infarct core (the center of the infarct), middle cerebral artery (MCA) borderzone (the edge of the brain regions supplied by the MCA), and the ischemic borderzone (border of ischemic lesion). Ischemic lesion size and neurological deficits were also assessed.

resultsBoth Hypo-treated and Hsp70 Tg mice had smaller lesion sizes and improved neurological outcomes, whereas Hsp70 Ko mice had larger lesion sizes and worsened neurological outcomes. Cofilin-actin rods were increased after stroke, but were reduced by therapeutic Hypo and in Hsp70 Tg mice. In contrast, cofilin-actin rods were increased in ischemic brains of Hsp70 Ko mice.

conclusionsCofilin-actin rod formation was suppressed under the conditions of neuroprotection and increased under circumstances where outcome was worsened. This suggests that cofilin-actin rods may act to participate in or exacerbate ischemic pathology and warrants further study as a potential therapeutic target.

Indexed as

Cofilin-actin rodheat shock protein 70hypothermianeuroprotectionstroke

Identifiers

PMID31950099
PMCPMC6950512
OpenAlexW2997400770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.